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Mouse osteoblastic lone MC3T3-El was proved as a target cell for retinoic acid (RA) in bone tissues through the demonstration of RA-receptor 
gene expression by the northern blot analysis. The effect of RA on the cell growth of MC3T3-El was repressive for both subconfluent and confluent 
growth, whereas RA enhancement of alkaline phosphatase xpression was observed at the confluent stage. This implies that RA is a regulatory 
factor leading osteogenesis of the cells after the confluent stage. RA exhibited simultaneously the stage-dependent effects on EGF-dependent mito- 
genesis: promotive at the subconfluent, but repressive at the confluent stage. 
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1. INTRODUCTION 
Retinoids play important roles in mammalian bone 
development [I]. Retinoids, in vitro, stimulate bone 
resorption in embryonic rat long bones [2] and inhibit 
collagen synthesis in chick and mouse calvaria [3]. 
These effects of retinoids suggest bone as a target tissue. 
Recently, we demonstrated by in situ hybridization for 
mRNAs of retinoic acid receptor (RAR) that the genes 
are expressed intensively and specifically in calcifying 
fronts of mouse finger bones during the development 
[4]. Thus, the specific target cells for retinoic acid (RA) 
and the action mechanism in bone tissues remain to be 
clarified. 
cells (4.5 x 104) was performed in 35 mm 0 plastic dish containing 
1.5 ml of u-modified minimum essential medium (ru-MEM)/lOI 
FCS for 2 days to the subconfluent growth and for 4 or 5 days to the 
confluent growth. The cells thus precultured were transferred into 
fresh (Y-MEM/2% FCS containing the varied RA (Sigma) concentra- 
tion. All cultures were conducted at 37°C in 5070 COr. 
2.2. RNA preparation and Northern blot analysis 
In the present study, we examined the expression of 
mRNA for RAR in mouse osteoblastic clone MC3T3- 
El by the northern blot analysis. Furthermore, we sur- 
veyed the primary effects of RA on the growth and al- 
kaline phosphatase (ALP) expression, as an essential 
step leading the osteogenesis, and the growth stage- 
dependent effects of RA on the epidermal growth fac- 
tor (EGF)-dependent mitogenesis. 
Total RNA of MC3T3-El cells were prepared by the guanidinium 
thiocyanate/CsCl method [6]. The RNA sample (10 fig per track) was 
size-fractionated on 1% agarose10.66 M formaldehyde gel and 
capillary-blotted on nylon membrane. The membrane was hybridized 
at 42°C overnight with the ‘*P-labeled probe (ld dpm/ml). The 
membrane was washed in 2 x SSC/l% SDS for 10 min at room tem- 
perature, 1 x SSC/l@/o SDS for 10 min at 68”C, 2 x SSC/RNase A 
(1 /cg/ml) for 5 min at 37”C, and finally 0.1 x SSC/l% SDS for 
10 min at 68°C. Autoradiography with intensifying screen was per- 
formed for 1 day at -70°C. Drs M. Petkovich and P. Chambon 
donated the human RARCV cDNA clone (ligand-binding region E) [7], 
from which the labeled RNA probe (sp. radioact. 5 x 10’ dpm/pg 
RNA) was prepared with [a-‘*P]UTP (Amersham). 
2.3. Assays of cell growth and ALP activity 
2. EXPERIMENTAL 
The cell number of MC3T3-El cells was counted by a Coulter 
counter after the treatment with 0.1% trypsin and 0.02% EDTA. For 
the ALP activity measurement, he cells were solubilized in 1 ml of 
0.2% Nonident P-40 and sonicated in an ice bath for 5 min, the 
lysates were centrifuged for 10 min at 3000 rpm, and the supernatants 
were used for the assay with solution (pH 9.8) containing 10 mM p- 
nitrophenyl phosphate at 37°C. An aliquot of each cell lysate was sub- 
jected to the protein assay using the Bradford’s method [8]. All con- 
trol cells were cultured with the vehicle (0.1 ‘J/o (v/v) ethanol). 
2.1. Cell culture 
Osteoblastic cells, clone MC3T3-El derived from C57BL/6 new- 
born mouse calvaria, were donated by Dr H. Kodama. The cell main- 
tenance and the cell cultures for Northern blot analysis were perform- 
ed with the procedure of Sudo et al. [5]. The preculture of MC3T3-El 
2.4. Assays of thymidine incorporation and EGF binding 
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To estimate the mitogenesis of MC3T3-El cells incubated in the ab- 
sence and presence of 10 ng/ml mouse EGF (Collaborative Re- 
search), the [‘Hlthymidine (0.25 pCi per dish, Amersham) incorpora- 
tion of the cells was measured by pulsing for 1 h. For the EGF binding 
of MC3T3-El cells cultured without added EGF, the cells were fixed 
with 0.2Vo paraformaldehyde and the binding assay with “‘1-EGF 
(sp. radioact. 168.2 dpm/fmol, iodinated by the chloramine-T meth- 
od 191) was performed with the method of Kawamoto et al. [IO]. 
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Fig. 1. Norkbern blot anatysis of RAR mRNA expressed in MC3T3Bl 
cehs cuhured in ~-ME~/I~~~ FCS. ~~5~5~~ RNAs (2g S and fg S) 
are indicated as size markers. (I) 27th day; (2) 7th day; (3) 2fst day. 
3. RESULTS 
The RAR mRNA (single band at about 3.1-3.3 kbp) 
was detected by the Northern blot analysis in MC3TJ- 
El cells cuttured up to the multilayer phase (21st day) 
(fig.]). 
The growth of MC3T3-El cells proceeds, after the in- 
oculation, from monolayer phase to mult~layer phase a- 
round 4-5th day where the cells finally differentiated 
into osteacytes and mineralized in the culture, as ob- 
served under the basal culture conditions [S]. The ALP 
specific activity stayed at a very low level at the sub- 
confluent stage in the monolayer phase, but was en- 
Fig.2. Effects of RA on the subconfluent growth (0) and the ALP 
activity (a) at the confluent stage of MC3T3-El cells. The data are 
mean values from 4 or 5 samples with the indicated SDs. 
harmed intensively after the cells reached the confluent 
stage. 
The exposure of MC3T3-E1 cells to 1K6 M RA 
brought about ~~~~ jnbibition of the monolayer growth 
{for 72 h from 2nd day), but about 180% enh~cement 
of the ALP specific activity at the confluent stage (for 
48 h from 5th day) (fig.2). However, the exposure of 
the sub~onfluent cells (for 48 h from 2nd day) to 
fOWh M RA did not affect the ALP specific activity 
si~nificantI~, and the cell growth at the confluent stage 
(for 72 h from 5th day) was repressed upon exposure to 
W6 M RA. 
As shown in figs,3A and 4, the rnito~e~~ effect of 
EGF on the growth of MC3T3-El cells without added 
RA was observed at both the subconfluent (for 16 h 
i. 0 G f RA CM) I 
Fig-J. {A) Effect of RA on the EGF mitogenicity of MC3T3-El cells 
in the subconfluent growth. With (a) and without (0) IO ng/ml of 
EGF. The data are means of dnp~i~te cuhures, (B) Dosage effect (@ 
of RA on tz’I-EGF binding capacity of MC3T3-El c&s at the sub” 
confluent stage. The non-specific binding level in the presence of ex- 
cess cold EGF was subtracted from the total binding to give the 
specific binding. The stimulative effect of EGF on DNA synthesis 
(0) estimated from fig.3A is also inserted. 
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Fig.4. Effect of RA on the EGF mitogenicity of MC3T3-El cellS in 
the confluent growth. With (0) and without (0) 10 ng/ml of EGF. 
The data are means of duplicate cultures. 
from 2nd day) and confluent (for 16 h from 4th day) 
stage. In the combination of RA and EGF, however, 
the effect of RA on the EGF-dependent growth ap- 
peared to be alternative: a promotive effect in the sub- 
confluent stage (fig.3A) whereas this was a repressive 
effect in the confluent stage (fig.4). The effect of RA on 
the binding of “‘1-EGF to the MC3T3-El subconfluent 
cells (for 14 h from 2nd day) is demonstrated in fig.3B. 
The level of specific EGF binding was enhanced in the 
RA-treated cells in a dose-dependent manner and, as so 
far tested, reached the highest level at IOV6 M RA. Fur- 
thermore, the enhancement of EGF binding appears to 
be in parallel with the RA enhancement of mitogenesis 
as estimated from fig.3A and illustrated in fig.3B. 
4. DISCUSSION 
Retinoids regulate growth and differentiation in a va- 
riety of cell lines including osteogenic ells such as os- 
teosarcomas and chondrosarcomas Ill]. RA differenti- 
ation of F9 teratocarcinoma stem cells is accompanied 
by the increased transcription of the specific genes [121, 
probably mediated through the specific nuclear RARs 
[7]. Since 3 subtypes of RAR (qu$,y) cDNA identified 
in mouse [ 131 and human [7,14,15] have high homology 
to each other, our probe from a cDNA of human RARcv 
possibly cross-hybridizes with those for the other two 
subtypes of mouse. Judged from the mRNA size esti- 
mated from the band of northern blot (fig.l), the de- 
tected mRNA are indicated as RAR@ and/or RARy. 
The RAR gene expression thus demonstrated in 
MC3T3-El cells presents, for the first time, direct evi- 
dence to identify the osteoblastic ells as target cells for 
the RA action, and substantiated the spatial expression 
pattern of RAR gene in mouse bone development as re- 
vealed by means of in situ hybridization [4] with RAR 
riboprobes as employed in the present study. 
Our results with MC3T3-El cells showed that the 
functional mode of RA is remarkably dependent on the 
culture stage (fig.2): the ~onffuent cells were, as in the 
subconfluent cells, susceptible to the growth repression 
effects of RA, whereas the ALP activity only of the 
confluent cells was enhanced by RA. It is of some in- 
terest to note that a similar mode of RA function has 
been reported in relatively undifferentiated bone 
mesenchymal cells such as UMR 201 from neonatal rat 
calvaria 1161. Thus, the RA enhancement of ALP ex- 
pression in the confluent MC3T3-El cells implies that 
RA is a regulatory factor initiating osteogenesis of os- 
teoblastic cells after the confluent stage. In this respect, 
what is noteworthy is the recent demonstration that 
RAR antisense DNAs inhibit ALP induction in malig- 
nant keratinocytes [17], suggesting the possibility that 
the RAR gene expression participates in regulatory ex- 
pression of ALP likewise in MC3T3-El cells. 
In MC3T3-El cells at the confluent stage, EGF alone 
exhibits a remarkably promotive effect on mitogenesis 
but a simultaneously repressive ffect on ALP expres- 
sion [18], as confirmed also in the present study. We 
elucidated the RA enhancement of the EGF-dependent 
subconfluent growth and of the EGF binding (fig.3). As 
reported with some fibroblastic and epidermal cell 
lines, RA enhances EGF binding with a concomitant in- 
crease of the receptor number [19,20]. The present re- 
sults with subconfluent MC3T3-El cells indicate that 
the amplified mitogenic effect is possibly mediated 
through the enhancement of EGF binding induced by 
RA. On the other hand, like the case of confluent 
mouse fibroblast Balb/c 3T6 cells [21], the repressive 
effect of RA on the EGF-dependent mitogenesis of the 
confluent MC3T3-El cells was also shown (fig.4). 
In conclusion, the stage-dependent functions of RA 
revealed in MC3T3-El cells are physiologically signifi- 
cant in view of the temporal switching of regulatory 
mode of RA, apparently in favour of osteogenesis after 
the confluent stage as characterized by RAR gene ex- 
pression as well as ALP level enhancement. 
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